Status:
COMPLETED
Effectiveness of Nebulized Dexmedetomidine for Treatment of Obstetric Post-Dural Puncture Headache
Lead Sponsor:
Zagazig University
Conditions:
Post-Dural Puncture Headache
Eligibility:
FEMALE
21-40 years
Phase:
NA
Brief Summary
Postdural puncture headache (PDPH) is a common complication, following neuraxial techniques. The obstetric population is particularly prone to PDPH. Therefore, treatment of PDPH is a key issue in obst...
Detailed Description
Post-Dural puncture headache (PDPH) is a well-known common devastating complication of subarachnoid block. Despite the decreasing incidences of PDPH over the last years due to the advancement in the d...
Eligibility Criteria
Inclusion
- Post-partum females diagnosed with PDPH after elective caesarean section under spinal anesthesia and with visual analogue score (VAS) ≥ 4 and Lybecker et al. classification score ≥2.
- Age 21- 40 years old.
- ASA I and ASA II.
- Accepted mental state of the patient.
Exclusion
- Patient refusal.
- ASA Grade III and IV.
- Emergent caesarean section.
- Inadequate temporal window.
- Hypertensive disorders of the pregnancy.
- Atrial fibrillation.
- History of allergy to local anesthetics.
- History of chronic headache, migraine, convulsions, and cerebrovascular accident.
- Contraindication to spinal anesthesia: coagulopathy, infection at site of injection
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04327726
Start Date
May 1 2020
End Date
February 28 2021
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University Hospitals
Zagazig, Sharqia Province, Egypt, 44519